Cellfina is the only FDA-cleared, minimally invasive procedure clinically proven to improve the appearance of cellulite for results that last at least two years – the longest duration cleared by the FDA.

"Merz Aesthetics is proud to bring Cellfina to physicians across the country. We chose the annual meeting of Aesthetic Plastic Surgeons as the venue to make this technology widely available because of the long heritage this meeting has of introducing key advances in aesthetics," said Patrick Urban, Vice President and Head of the Merz Aesthetics Device Division.

"Additionally, the new Cellfina safety and efficacy data we will be presenting at the meeting are further evidence of Merz Aesthetics’ commitment to continued innovation and expansion of the aesthetic space."

The Cellfina System presentation (Abstract 341), titled "Pivotal Safety and Efficacy Study of a New Precision-Guided Tissue Release Cellulite Treatment" will be presented by Dr. Simeon Wall and will highlight new outcome data from the pivotal prospective, multi-centered study.

"As one of the very early adopters of Cellfina, it is exciting to see technology added to our tool chest. This transformative device will impact and expand the aesthetic market and provides an accurate and successful treatment option for our patients that is minimally invasive and can be performed under local anesthesia," said Dr. Brad Bengtson, a board-certified plastic surgeon from Grand Rapids, MI.

"The immediate results and significant improvement in the outcomes is proof enough for me that we finally have something that actually works for dimpled cellulite."

The Cellfina System is intended for long-term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females. Safety and effectiveness in other anatomical areas have not been established.

The most common side effects reported were soreness, tenderness, and bruising. The Cellfina System is only available through a licensed physician.